A two-part phase 1 study to establish and compare the safety and local tolerability of two nasal formulations of XF-73 for decolonisation of Staphylococcus aureus: A previously investigated 0.5 mgig viscosified gel formulation versus a modified formulation Article (Web of Science)

cited authors

  • Yendewa, George A.; Griffiss, J. McLeod; Jacobs, Michael R.; Fulton, Scott A.; O'Riordan, Mary Ann; Gray, Wesley A.; Proskin, Howard M.; Winkle, Peter; Salata, Robert A.

publication date

  • June 1, 2020




  • Antimicrobial resistance
  • Decolonisation
  • Staphylococcus aureus
  • XF-73

start page

  • 171

end page

  • 180


  • 21